Melanoma drug 'fast-tracked'

Article

West Haven, Conn. - The kidney cancer drug Nexavar has been granted fast track designation by the Food and Drug Administration for treatment of advanced melanoma, manufacturer Bayer Pharmaceuticals announced.

West Haven, Conn. - The kidney cancer drug Nexavar has been granted fast track designation by the Food and Drug Administration for treatment of advanced melanoma, manufacturer Bayer Pharmaceuticals announced.

Nexavar was approved last year for treatment of renal cell carcinoma.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.